Health
Novel Rapid Lateral Flow Immunoassay Can Function as `Suitcase Laboratory` for On-Site Detection of COVID-19 – HospiMedica
Scientists have developed a novel amplification-free rapid SARS-CoV-2 nucleic acid detection platform based on hybrid capture fluorescence immunoassay (HC-FIA)…
Scientists have developed a novel amplification-free rapid SARS-CoV-2 nucleic acid detection platform based on hybrid capture fluorescence immunoassay (HC-FIA) to fulfill the need for rapid and accurate nucleic acid detection at the point of care.The use of the monoclonal antibody S9.6 is the distinctive feature of this process developed by scientists from the Suzhou Institute of Biomedical Engineering and Technology (Suzhou, China). The process recognizes DNA-RNA double-stranded hybrids and enables…
-
Noosa News15 hours agoSearch for man who ‘faked death’ slowed by unusual French law
-
Noosa News21 hours agoQueensland Rail retires iconic electric train fleet after more than four decades
-
Business17 hours ago2 ASX 200 large-cap shares that this fundie is cashing in after phenomenal growth
-
Noosa News17 hours agoAustralia’s biggest sheep drive, and the young drover history forgot